According to the annual report of JSC Pharmasyntez (Irkutsk), in Q1 2018, the company plans to complete the construction and commissioning of a new plant for manufacturing the active pharmaceutical substances in Bratsk (Irkutsk region).
In addition, the company is currently designing Phase 2 of its facility for manufacturing antitumor medicinal products in St. Petersburg. The commissioning of Phase 2 is expected at the end of 2019.
According to the report, in Tyumen, the company began the construction of a new workshop to produce hormonal drugs and is currently preparing its construction site. The project is scheduled for implementation in 2017-2019. The investments are estimated at 3.25 billion rubles.
Pharmasyntez also plans to launch a new workshop of low-tonnage manufacturing in Irkutsk in September 2017.
According to the company’s forecasts, start-up of all these capacities will triple its output.